PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7.83

Change

+0.09 (+1.16)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.02 (+3.87%)

USD 9.27B
FNGU MicroSectors FANG+ Index 3X Le..

+29.11 (+4.62%)

USD 8.18B
QLD ProShares Ultra QQQ

+2.64 (+2.35%)

USD 6.67B
SSO ProShares Ultra S&P500

+1.28 (+1.33%)

USD 5.30B
UPRO ProShares UltraPro S&P500

+1.81 (+1.93%)

USD 4.36B
TECL Direxion Daily Technology Bull..

+3.87 (+4.41%)

USD 3.09B
YINN Direxion Daily FTSE China Bull..

+2.60 (+7.72%)

USD 1.89B
USD ProShares Ultra Semiconductors

+3.31 (+5.54%)

USD 1.15B
UDOW ProShares UltraPro Dow30

+1.09 (+1.04%)

USD 0.85B
DPST Direxion Daily Regional Banks ..

-4.08 (-3.12%)

USD 0.83B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.28% 55% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.28% 55% F 88% B+
Trailing 12 Months  
Capital Gain -15.81% 12% F 13% F
Dividend Return 0.84% 39% F 11% F
Total Return -14.97% 12% F 12% F
Trailing 5 Years  
Capital Gain -71.13% 15% F 5% F
Dividend Return 1.03% 16% F 3% F
Total Return -70.10% 15% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 57.56% 79% B- 95% A
Dividend Return 58.14% 79% B- 94% A
Total Return 0.58% 41% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 392.93% 15% F 3% F
Risk Adjusted Return 14.80% 25% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.